Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Replication-defective dengue viruses that are replication-defective in mosquitoes for use as vaccines

Replication-defective dengue viruses that are replication-defective in mosquitoes for use as vaccines

US Patent 6685948 · Granted Feb 3, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chair2025
Array substrate, display panel and manufacturing method thereof2025
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-2023
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-2020
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-2017
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-2017
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-2017
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-2011
West Nile viruses with mutations in the 3′ terminal stem and loop secondary stru2010
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-2009